| Absorption |
| Blood-Brain Barrier | BBB+ | 0.8219 |
| Human Intestinal Absorption | HIA+ | 0.9443 |
| Caco-2 Permeability | Caco2+ | 0.5000 |
| P-glycoprotein Substrate | Non-substrate | 0.8243 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9823 |
| Non-inhibitor | 0.9787 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9387 |
| Distribution |
| Subcellular localization | Mitochondria | 0.5980 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8445 |
| CYP450 2D6 Substrate | Non-substrate | 0.9099 |
| CYP450 3A4 Substrate | Non-substrate | 0.8284 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9406 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9270 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9699 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9543 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9754 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9504 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9658 |
| Non-inhibitor | 0.9761 |
| AMES Toxicity | Non AMES toxic | 0.8027 |
| Carcinogens | Carcinogens | 0.6178 |
| Fish Toxicity | Low FHMT | 0.9308 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.8865 |
| Honey Bee Toxicity | High HBT | 0.7421 |
| Biodegradation | Ready biodegradable | 0.5511 |
| Acute Oral Toxicity | III | 0.5222 |
| Carcinogenicity (Three-class) | Non-required | 0.6375 |